FDA approves heart valve that grows with pediatric patients
· Health · United States
A replacement heart valve that grows with the patient won FDA approval, potentially reducing repeat open-heart surgeries for children born with certain heart defects. It addresses a long-standing limitation of fixed-size implants.
Why it matters:Growth-adaptive implants could change surgical planning and lifetime costs for congenital heart disease, a niche with high unmet need.
Key points
- The valve is designed to grow with the patient
- It could mean fewer open-heart surgeries for children with certain heart defects
Sources (original reporting)
More stories from this day
- Lilly posts best weight-loss data; Bayer plans $2.2B Ohio plant; Aviceda shuts down
- FDA finds cyclospora at Mexican farm tied to lettuce outbreak
- FDA opens clinical trial modernization office; NIH redesigns public website
- California subpoenas OpenAI over AI agents used in hacking incidents
- G7 to release 100 million barrels of diesel and crude reserves
- Bipartisan US Senate deal aims to speed energy permitting